Gian Piero Reverberi Net Worth & Insider Trades

Gian Piero Reverberi - SVP & Chief Commercial Officer, Vanda Pharmaceuticals Inc

As of March 4, 2020

What is Gian Piero Reverberi's Net Worth?

The current estimated net worth of Vanda Pharmaceuticals Inc's SVP & Chief Commercial Officer, Gian Piero Reverberi, is estimated to be about $1.8M . Gian Piero Reverberi owns about 165,384 units of Vanda Pharmaceuticals Inc common stock. In the last 5 years at Vanda Pharmaceuticals Inc, Gian Piero Reverberi has sold an estimated value of $81K worth.

What is Gian Piero Reverberi's Past Insider Trading?

Gian Piero Reverberi's largest sale order was 1,130 units , worth over $30.04K on January 4, 2019. In total, Gian Piero Reverberi has made about 11 transactions over 5 years of their time at Vanda Pharmaceuticals Inc. Gian Piero Reverberi usually trades in March, with the busiest year in 2019. The most recent transaction was a sale order of 1,450 units , worth over $14.76K on March 4, 2020.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Gian Piero Reverberi's' Mailing Address?

  • Mailing address is 2200 Pennsylvania Avenue Suite 300e Washington DC 20037 DC

Vanda Pharmaceuticals Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Mihael H. Polymeropoulos, M.D. 2020 $746,235 - $679,200 $795,830 $656,687 $35,468 $2,913,420
Mihael H. Polymeropoulos, M.D. 2019 $721,000 - $1,237,200 $1,610,154 $675,000 $34,783 $4,278,137
Mihael H. Polymeropoulos, M.D. 2018 $700,000 - $1,131,000 $1,456,406 $700,000 $37,322 $4,024,728
James P. Kelly 2020 $124,057 - - - - $16,217 $140,274
James P. Kelly 2019 $493,370 - $618,600 $805,077 $288,622 $42,741 $2,248,410
James P. Kelly 2018 $479,000 - $754,000 $832,232 $299,375 $36,778 $2,401,385
Kevin Moran 2020 $324,693 - $331,101 $427,779 $200,000 $36,126 $1,319,699
Joakim Wijkstrom 2020 $506,422 - $339,600 $397,915 $250,679 $29,269 $1,523,885
Aranthan "AJ" Jones II 2020 $406,104 - $339,600 $397,915 $201,021 $33,677 $1,378,317
Timothy Williams 2020 $400,000 - $339,600 $397,915 $200,000 $41,546 $1,379,061
Timothy Williams 2019 $379,315 - $618,600 $805,077 $177,520 $42,342 $2,022,854
Timothy Williams 2018 $144,886 $40,000 $643,500 $1,086,894 $71,918 $15,658 $2,002,856
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1347178/000134717821000008/vnda-20210422xdef14a.htm

What are Vanda Pharmaceuticals Inc's Past Insider Trades?

Vanda Pharmaceuticals Inc's most recent insider trade came on August 1, 2022 by Kevin Patrick Moran who sold 2,239 units worth $24.56K . In the last 16 years, insiders at Vanda Pharmaceuticals Inc have sold an estimated value of $295.97M and bought an estimated value of $28.25M worth of shares. Insider trading is most common in June, with the busiest year in 2006. The most active traders at the company are Mihael Polymeropoulos, President and CEO,  James P. Kelly, EVP & Chief Financial Officer,  and Richard W Dugan, Director .

Vanda Pharmaceuticals Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1